Financial toxicity in cancer patients treated with radiotherapy in Germany—a cross-sectional study
Open Access
- 25 April 2022
- journal article
- research article
- Published by Springer Nature in Strahlentherapie und Onkologie
- Vol. 198 (12) , 1053-1061
Abstract
Purpose: Financial toxicity arises in cancer patients from subjective financial distress due to objective financial burden from the disease or treatment. Financial toxicity associates with worse outcomes. It has not been described in cancer patients undergoing radiotherapy in Germany and its publicly funded health system. In this context, we therefore investigated the prevalence of financial toxicity, associated risk factors, and patient preferences on communication of financial burden. Methods: We conducted a preregistered (https://doi.org/10.17605/OSF.IO/KH6VX) cross-sectional study surveying patients at the end of their course of radiotherapy in two institutions. Objective financial burden was assessed by direct costs and loss of income. Financial toxicity was measured by subjective financial distress per EORTC QLQ-C30. We used Spearman’s correlation and Fisher’s exact test for univariate analysis, an ordinal regression for multivariate analysis. A p-value < 0.05 was considered statistically significant. Results: Of the 100 patients participating in the study, 68% reported direct costs, 25% loss of income, and 31% subjective financial distress. Per univariate analysis, higher subjective financial distress was significantly associated with active employment, lower quality of life, lower household income, higher direct costs, and higher loss of income. The latter three factors remained statistically significant in the multivariate analysis. A relative majority of the patients welcomed communication regarding financial burden with their radiation oncologist. Conclusion: Financial toxicity is prevalent in cancer patients treated with radiotherapy in Germany. The reported risk factors may help to identify patients at risk. Future studies should validate these results and investigate interventions for financial toxicity to potentially improve outcomes.Keywords
Funding Information
- Universitätsklinikum Schleswig-Holstein - Campus Kiel
This publication has 26 references indexed in Scilit:
- The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in ItalyAnnals of Oncology, 2016
- Self‐reported financial burden of cancer care and its effect on physical and mental health‐related quality of life among US cancer survivorsCancer, 2016
- Patient Attitudes Regarding the Cost of Illness in Cancer CareThe Oncologist, 2015
- Impact of Financial Burden of Cancer on Survivors' Quality of LifeJournal of Oncology Practice, 2014
- Self-Reported Financial Burden and Satisfaction With Care Among Patients With CancerThe Oncologist, 2014
- The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's ExperienceThe Oncologist, 2013
- Out-of-Pocket Costs in the Year After Early Breast Cancer Among Canadian Women and SpousesJNCI: Journal of the National Cancer Institute, 2013
- National Estimates of Out-of-Pocket Health Care Expenditure Burdens Among Nonelderly Adults With Cancer: 2001 to 2008Journal of Clinical Oncology, 2011
- Adjusting for multiple testing—when and how?Journal of Clinical Epidemiology, 2001
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993